BioNtech/Pfizer N=34 | Moderna N=20 | Oxford/AstraZeneca N=32 | p-value | |
---|---|---|---|---|
Maternal characteristics | ||||
Age (years) | 34.2 ±4.1 | 34.8 ±3.1 | 34.7 ±3.6 | 0.802 |
Chronic diseases (hypothyroidism, heart disease) | 8 (23.5%) | 5 (33.3%) | 6 (18.75%) | 0.841 |
Medication | 5 (14.7%) | 3 (14.3%) | 3 (9.4%) | 0.782 |
Gestational age (weeks) | 39.2 ±2.1 | 39.4 ±1.4 | 39.9 ±1.4 | 0.246 |
Education degree (high-degree university studies) | 32 (94.1%) | 19 (95.2%) | 29 (90.6%) | 0.792 |
SARS-CoV-2-positive PCR before vaccine | 6 (17.1%) | 2 (9.5%) | 0 (0.0%) | - |
Infant characteristics | ||||
Gender (female, %) | 10 (29.4%) | 9 (45%) | 17 (53.1%) | 0.141 |
Mode of birth (C-section, %) | 10 (29.4%) | 6 (30%) | 6 (18.7%) | 0.535 |
Weight at birth (g) | 3308.4 ±420.6 | 3495.0 ±616.8 | 3457.8 ±369.1 | 0.262 |
Length at birth (cm) | 50.8 ±2.1 | 50.5 ±2.4 | 51.1 ±1.8 | 0.591 |
Infant age at maternal vaccination (month) | 14.3±11 | 11.0±5.2 | 12.4±7.6 | 0.385 |
Exclusive breastfeeding at maternal vaccination (%) | 5 (14.7%) | 3 (15%) | 4 (12.5%) | 0.956 |